价格

I-17

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
US 8278469 B2申请人: SCHWEDE WOLFGANG优先权: 2009
EP
US
6 件公开
MINIMAL NEPHRIN PROMOTER
EP 4305181 B1申请人: UNIV BRISTOL优先权: 2021
CN
EP
US
WO
5 件公开
USE OF A LIMOSILACTOBACILLUS FERMENTUM BACTERIAL STRAIN ALONE OR IN COMBINATION WITH SACCHAROMYCES CEREVISIAE FOR PREVENTING AND/OR TREATING VAGINAL CANDIDIASIS
US 20250064868 A1申请人: LESAFFRE & CIE优先权: 2021
CN
EP
US
WO
4 件公开
A MODIFIED PROTEIN SCAFFOLD AND USE THEREOF
EP 4594347 A2申请人: EVOLVERITAS BIOTECHNOLOGIAI KORLATOLT FELELOSSEGU TARSASAG优先权: 2022
CN
EP
US
WO
4 件公开
17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases
US 9206219 B2申请人: KLAR ULRICH优先权: 2009
CN
US
4 件公开
Inhibitors of CYP 17
US 8263635 B2申请人: BOCK MARK G优先权: 2009
US
4 件公开
17-hydroxylase/C17,20-lyase inhibitors
US 9029399 B2申请人: BOCK MARK GARY优先权: 2011
US
4 件公开
17Beta-Alkyl-17Alpha-oxy-estratrienes
US 2012157421 A1申请人: BOHLMANN ROLF优先权: 2009
CN
EP
US
3 件公开
IMIDAZOTRIAZINE DERIVATIVES AS IL-17 MODULATORS
- EP 4363421 A1
  申请人: UCB BIOPHARMA SRL优先权: 2021
  EP
  US
  WO
  3 件公开
- EP 4698532 A1
  申请人: UCB BIOPHARMA SRL优先权: 2023
  CN
  EP
  WO
  3 件公开
(17-)-3-OXOANDROST-4-EN-17-YL DODECANOATE COMPOSITIONS AND METHODS OF PREPARATION AND USE
EP 4543458 A4申请人: LIPOCINE INC优先权: 2022
CN
EP
WO
3 件公开

药物

I-17

专利

IMIDAZOTRIAZINE DERIVATIVES AS IL-17 MODULATORS